San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...
Series A financing will advance the company’s lead candidate for heart failure with reduced ejection fraction (HFrEF) through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback